Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science by Ann, John
1UOB Open
Suicide risk and prevention during the COVID19 pandemic.
The mental health effects of the COVID-19 pandemic might be profound[1] and there are 
suggestions that suicide rates will rise, though this is not inevitable. Suicide is likely to become a 
more pressing concern as the pandemic spreads and has longer-term effects on the general 
population, the economy and vulnerable groups. Preventing suicide therefore needs urgent 
consideration. The response must capitalise on, but extend beyond, general mental health policies 
and practices.
There is some evidence that suicides increased in the USA during the 1918-19 influenza 
pandemic[2]and among older people in Hong Kong during the 2003 SARS epidemic[3].The current 
context is different and evolving. A wide-ranging interdisciplinary response that recognises how the 
pandemic might heighten risk and applies knowledge about effective suicide prevention approaches 
is key. Selective, indicated and universal interventions are required (see Panel).
The likely adverse effects of the pandemic on people with mental illness, and on population mental 
health in general, might be exacerbated by fear, self-isolation and physical distancing[4]. Suicide risk 
might be increased because of COVID19-related stigma towards affected individuals and their 
families. Those with psychiatric disorders might experience worsening symptoms and others might 
develop new mental health problems, especially depression, anxiety and post-traumatic stress (all 
associated with increased suicide risk). These will be experienced by the general population and 
those with high levels of exposure, like frontline health care workers. The consequences for mental 
health services are already being felt (e.g., increased workloads and the need to find new ways of 
working). Some services are developing expertise in conducting psychiatric assessments and 
delivering interventions remotely (e.g., by telephone, digitally); this should be implemented more 
widely, but with consideration that not all patients will feel comfortable with such interactions and 
they may present implications for privacy. Making evidence-based online resources and 
interventions freely available at scale could benefit population mental health.
People in suicidal crises require special attention. Some might not seek help, fearing that services are
overwhelmed and that attending face-to-face appointments might put them at risk. Others might 
seek help from voluntary sector crisis helplines which might be stretched beyond capacity due to 
surges in calls and reductions in volunteers. Mental health services should develop clear remote 
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assessment and care pathways for suicidal individuals and staff training to support new ways of 
working (see Royal College of Psychiatrists guidance: https://www.rcpsych.ac.uk/about-
us/responding-to-covid-19/responding-to-covid-19-guidance-for-clinicians). Helplines will require 
support to maintain/increase their volunteer workforce and offer them more flexible methods of 
working. Digital training resources would enable those who have not previously worked with suicidal
individuals to take active roles in mental health services and helplines. Evidence-based online 
interventions and apps should be made available to support suicidal individuals[5].
Loss of employment and financial stressors are well-recognised risk factors for suicide[6]. 
Governments should provide financial safety nets (e.g., food/housing/unemployment supports). 
Consideration must be given not only to individuals’ current situations but also their futures. For 
example, many young people have had their education interrupted and are anxious about their 
prospects. Educational institutions must seek alternative ways to deliver curricula and governments 
need to be prepared to offer them financial support if necessary. Active labour market programmes 
will also be crucial [6].
The pandemic might adversely affect other known precipitants of suicide. For example, domestic 
violence and alcohol consumption might increase during lockdown. Public health responses must 
ensure that those facing interpersonal violence are supported and that safe drinking messages are 
communicated. Social isolation, entrapment and loneliness contribute to suicide risk [7] and are 
likely to increase during the pandemic, particularly for bereaved individuals. Providing community 
support for those living alone and encouraging families/friends to ‘check in’ is helpful. Easily 
accessible help for bereaved individuals is critical. 
Access to means is a major risk factor for suicide. In the current environment, certain lethal means 
(e.g. firearms/pesticides/analgesics) might be more readily available, ‘stockpiled’ in homes. Retailers 
selling such products should be especially vigilant when dealing with distressed individuals. 
Governments and NGOS should consider temporary sales restrictions (e.g. on quantities) and deliver 
carefully framed messages about reducing access to commonly used and highly lethal suicide means.
Irresponsible media reporting of suicide can lead to spikes in suicides [8]. Repeated exposure to 
stories about the crisis can increase fear[9] and heighten suicide risk. Media professionals should 
ensure that reporting follows existing [10] and COVID-19-specific guidelines 
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(https://www.iasp.info/pdf/2020_briefing_statement_ABversion_reporting_on_suicide_during_covi
d19.pdf).
Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk 
factors contributing to suicidal behaviours. Some suicide and self-harm registers are now collecting 
data on COVID-19-related stressors contributing to the episode, summaries of these data will 
facilitate timely public health responses. Repeat representative cross-sectional and longitudinal 
surveys will help identify increases in population-level risk, as might anonymised real-time data on 
caller concerns from helplines. Monitoring demands and capacity of mental healthcare providers 
over coming months is also essential to ensure resources are directed to those parts of the system 
under greatest pressure. These efforts need to be appropriately resourced and coordinated.
The suicide-related consequences of the pandemic might vary depending on countries’ public health 
control measures, sociocultural/demographic structures, availability of digital alternatives to face-to-
face consultation and existing supports. The effects might be worse in resource poor settings where 
economic adversity will be compounded by inadequate welfare supports. Other concerns in these 
settings include social effects of banning religious gatherings and funerals, interpersonal violence, 
unintended consequences of alcohol bans, and vulnerable migrant workers. COVID-19 related stigma
and misinformation may be particularly acute in these settings. Many of the solutions proposed 
above will be applicable globally, but additional efforts will be required in resource poor settings.
These are unprecedented times. The pandemic will cause distress and leave many vulnerable. 
Mental health consequences are likely to be present for longer and peak later than the actual 
pandemic. However, research evidence and the experience of national strategies provide a strong 
basis for suicide prevention. We should be prepared to take the actions highlighted here, backed by 
vigilance and international collaboration.
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